What does CUSIP 44486Q103 represent in this 13F holders report?

CUSIP 44486Q103 is the security identifier for HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share in Q4 2021?

58 institutional investors reported HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

Humacyte, Inc. - Common Stock, par value $0.0001 per share (HUMA)

CUSIP: 44486Q103

Q4 2021 13F Holders as of 31 Dec 2021

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 9,522,696
Total 13F value: $69,016,600
Share change: +2,241,069
Put/Call ratio: 36%
SEC-reported price per share: $7.25
Number of holders: 58
Value change: +$7,310,797
Number of buys: 45
Number of sells: 12
Shares outstanding: 269,769,473

Security key

44486Q103

Report period

Q4 2021

Institutions

Top holders

HUMA full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2022 Previous quarter: Q3 2021 Humacyte, Inc. SEC filings Humacyte, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 44486Q103

Newer quarter: Q1 2022 Previous quarter: Q3 2021

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FRESENIUS MEDICAL CARE HO...

Disclosed value leader

FRESENIUS MEDICAL CARE HO...

Comparable rows

15/15

Latest evidence

30 Sep 2021

3/4/5 13F Lead comparable stake: 6.8% Showing 1-6 of 15 holder rows.

Quick read

FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ leads the comparable SEC ownership view at 6.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.

Comparable ownership Top 5

FRESENIUS MEDICAL CARE HOLDINGS I... 6.8%

York Capital Management Global Ad... 0.85%

ORBIMED ADVISORS LLC 0.56%

Diameter Capital Partners LP 0.35%

Monashee Investment Management LLC 0.28%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/	3/4/5 Former 10% Shareholder 3/4/5	6.8%	$21,792,154 18,312,735 shares	—	26 Aug 2021
York Capital Management Global Advisors, LLC	13F Company 13F	0.85%	$20,590,000 2,291,397 shares	—	30 Sep 2021
ORBIMED ADVISORS LLC	13F Company 13F	0.56%	$17,415,000 1,500,000 shares	—	30 Sep 2021
Diameter Capital Partners LP	13F Company 13F	0.35%	$11,078,000 954,138 shares	—	30 Sep 2021
Monashee Investment Management LLC	13F Company 13F	0.28%	$8,708,000 750,000 shares	—	30 Sep 2021
Maven Securities LTD	13F Company 13F	0.19%	$5,805,000 500,000 shares	—	30 Sep 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,522,696

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 value	Q4 2021 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend